The role of neuro-immune cross-talk in the regulation of inflammation and remodelling in asthma
Authors:
- Sabine RochlitzerSRSabine Rochlitzer
- Armin BraunABArmin Braun
- 1 May 2009
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 122 (2) , 203-214
Abstract
No abstract availableKeywords
This publication has 179 references indexed in Scilit:
- Hot target on nociceptors: perspectives, caveats and unique featuresBritish Journal of Pharmacology, 2008
- Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gasesThe FASEB Journal, 2008
- Correlation between immune and neuronal parameters and stress perception in allergic asthmaticsClinical & Experimental Allergy, 2007
- Capsaicin‐induced mucus secretion in rat airways assessedin vivoand non‐invasively by magnetic resonance imagingBritish Journal of Pharmacology, 2007
- Airway hyper‐responsiveness in allergic asthma in guinea‐pigs is mediated by nerve growth factor via the induction of substance P: a potential role for trkAClinical & Experimental Allergy, 2006
- Novel concepts of neuropeptide-based drug therapy: Vasoactive intestinal polypeptide and its receptorsEuropean Journal of Pharmacology, 2006
- The transient receptor potential vanilloid 1: Role in airway inflammation and diseaseEuropean Journal of Pharmacology, 2006
- Nerve growth factor: The central hub in the development of allergic asthma?European Journal of Pharmacology, 2006
- Allergic airway inflammation induces tachykinin peptides expression in vagal sensory neurons innervating mouse airwaysClinical & Experimental Allergy, 2005
- SR 142801, a tachykinin NK3 receptor antagonist, prevents β2-adrenoceptor agonist-induced hyperresponsiveness to neurokinin A in guinea-pig isolated tracheaLife Sciences, 2002